206 related articles for article (PubMed ID: 12044452)
1. Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism.
Díaz A; Pazos A; Flórez J; Ayesta FJ; Santana V; Hurlé MA
Neuroscience; 2002; 112(2):345-53. PubMed ID: 12044452
[TBL] [Abstract][Full Text] [Related]
2. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
Hurlé MA
J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
[TBL] [Abstract][Full Text] [Related]
3. Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.
Ferrer-Alcón M; La Harpe R; García-Sevilla JA
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):114-22. PubMed ID: 14969742
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with the opioid antagonist naltrexone favours the coupling of spinal cord μ-opioid receptors to Gαz protein subunits.
Valdizán EM; Díaz A; Pilar-Cuéllar F; Lantero A; Mostany R; Villar AV; Laorden ML; Hurlé MA
Neuropharmacology; 2012 Feb; 62(2):757-64. PubMed ID: 21903117
[TBL] [Abstract][Full Text] [Related]
5. Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord.
Patel CN; Rajashekara V; Patel K; Purohit V; Yoburn BC
Synapse; 2003 Oct; 50(1):67-76. PubMed ID: 12872295
[TBL] [Abstract][Full Text] [Related]
6. Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons.
Walwyn W; Evans CJ; Hales TG
J Neurosci; 2007 May; 27(19):5092-104. PubMed ID: 17494695
[TBL] [Abstract][Full Text] [Related]
7. Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord.
Patel M; Gomes B; Patel C; Yoburn BC
Eur J Pharmacol; 2002 Jun; 446(1-3):37-42. PubMed ID: 12098583
[TBL] [Abstract][Full Text] [Related]
8. Involvement of beta-arrestin-2 in modulation of the spinal antinociception induced by mu-opioid receptor agonists in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Nagase H; Dun NJ; Tseng LF
Neurosci Lett; 2003 Jul; 346(1-2):13-6. PubMed ID: 12850536
[TBL] [Abstract][Full Text] [Related]
9. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
10. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
11. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
12. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats.
Vinge LE; Øie E; Andersson Y; Grøgaard HK; Andersen G; Attramadal H
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2490-9. PubMed ID: 11709416
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptor kinases, beta-arrestin-2 and associated regulatory proteins in the human brain: postmortem changes, effect of age and subcellular distribution.
Grange-Midroit M; García-Sevilla JA; Ferrer-Alcón M; La Harpe R; Walzer C; Guimón J
Brain Res Mol Brain Res; 2002 May; 101(1-2):39-51. PubMed ID: 12007830
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to μ-opioid receptor-mediated anti-nociception is determined by cross-regulation between μ- and δ-opioid receptors at supraspinal level.
Ballesta JJ; Cremades J; Rodríguez-Muñoz M; Garzón J; Faura CC
Br J Pharmacol; 2012 May; 166(1):309-26. PubMed ID: 22023056
[TBL] [Abstract][Full Text] [Related]
16. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
17. Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2.
Lam H; Maga M; Pradhan A; Evans CJ; Maidment NT; Hales TG; Walwyn W
Mol Pain; 2011 Apr; 7():24. PubMed ID: 21486473
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
[TBL] [Abstract][Full Text] [Related]
19. Enhanced morphine analgesia in mice lacking beta-arrestin 2.
Bohn LM; Lefkowitz RJ; Gainetdinov RR; Peppel K; Caron MG; Lin FT
Science; 1999 Dec; 286(5449):2495-8. PubMed ID: 10617462
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
